전립선암에서 신경내분비세포 분화에 따른 병리학적 특성 = Pathological Characteristics of Neuroendocrine Cell Differentiation in Prostate Cancer

참고문헌 (Reference)

1 홍성준, "전립선비대증에서 신경내분비세포의 분포와 디하이드로테스토스테론의 영향" 대한비뇨기과학회 44 (44): 267-271, 2003

2 김준모, "가토의 전립선에서 신경내분비세포와 Survivin의 발현" 대한비뇨기과학회 47 (47): 201-205, 2006

3 Cohen RJ, "The neuroendocrine cell population of the human prostate gland" 150 : 365-368, 1993

4 Bonkhoff H, "Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate" 19 : 91-98, 1991

5 Adlakha H, "Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases" 25 : 135-139, 1994

6 Speights VO Jr, "Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples" 80 : 281-286, 1997

7 di Sant'Agnese PA, "Neuroendocrine differentiation in prostatic malignancy" 78 : 357-361, 1996

8 Jiborn T, "Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment" 51 : 585-589, 1998

9 Abrahamsson PA, "Neuroendocrine differentiation in prostatic carcinoma" 39 : 135-148, 1999

10 Hirano D, "Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy" 45 : 586-592, 2004

11 di Sant'Agnese PA, "Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications" 70 (70): 254-268, 1992

12 Xing N, "Neuroendocrine cells in human prostate over-express the anti- apoptosis protein survivin" 48 : 7-15, 2001

13 Bonkhoff H, "Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status" 8 (8): 18-22, 1998

14 Yu DS, "Modulation of prostate carcinoma cell growth and apoptosis by chromogranin A" 170 : 2031-2035, 2003

15 Pollack A, "Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02" 22 : 2133-2240, 2004

16 Grobholz R, "Influence of neuroendocrine tumor cells on proliferation in prostatic carcinoma" 36 : 562-570, 2005

17 Borre M, "Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantly" 1 : 268-275, 1998

18 Pretl K, "Frage der Endokrinie der menschleichen Vorsteherdruse" 312 : 392-404, 1994

19 Lee JJ, "Expression of endocrine cells in the prostate of rat and guinea pig after orchiectomy" 45 : 1148-1155, 2006

20 Theodoropoulos VE, "Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications" 66 : 897-902, 2005

21 Grobholz R, "Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma" 196 : 277-284, 2000

22 Sciarra A, "Chromogranin A expression in familial versus sporadic prostate cancer" 66 : 1010-1014, 2005

23 Isshiki S, "Chromogranin A concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancer" 167 : 512-515, 2002

24 Pruneri G, "Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy" 34 : 113-120, 1998

25 Aprikian AG, "Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma" 71 : 3952-3965, 1993

26 Cher ML, "Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression" 26 : 87-93, 1995

27 Islam MA, "Are neuroendocrine cells responsible for the development of benign prostatic hyperplasia?" 42 : 79-83, 2002

28 Allen FJ, "Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?" 75 : 751-754, 1995